Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BDX vs GSK✓SelectedUSD · GSKBDX vs GSK performance historyLatest closeAs of+1.08%11/13
Stock and ETF performance explorer

BDX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.1%
GSK return
+65.8%
Excess return
-40.8%
Maximum drawdown
-33.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%+0.5%+0.6%+0.9%
7D+2.9%+1.1%+1.8%+2.5%
30D+15.4%+6.3%+9.1%+12.9%
3M+20.5%+1.8%+18.7%+19.6%
6M+53.2%+1.7%+51.5%+52.0%
YTD+45.7%+6.5%+39.1%+42.1%
1Y+47.3%+9.5%+37.8%+42.5%
3Y+25.1%+65.3%-40.3%+5.0%
All+25.1%+65.8%-40.8%+5.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling